In Vitro Diagnostics (IVD) Market
In Vitro Diagnostics (IVD) Market - Overall Industry Analysis
Progressive Markets published a report, “In Vitro Diagnostics (IVD) Market by segmented (instruments, reagents, and services & software), By End user (hospitals, standalone laboratory, academics & medical schools, point of care and others)-Global Industry opportunity, Analysis, Forecast, 2016-2025,” which says that the IVD market is expected to garner $91.3 billion by 2025, registering a CAGR of 4.5% from 2017 to 2025.
In vitro diagnostics (IVD) refers to the technique that makes use of medical reagents and devices to examine samples of tissues, urine, stool, blood, and other body fluids for the assessment of diseases and infections. The tests are conducted in hospital based laboratories, stand-alone laboratories, and point of care testing centers. Some of the important technologies used for test sample preparation include microarray techniques, mass spectrometry, polymerase chain reaction (PCR), and sequencing technology. Doctors and researchers have turned to personalized medicines from traditional diagnostic methods due to new innovations in IVD product designs and technologies.
Market Drivers and Restraints:
The report identifies the propellers of the in vitro diagnostics (IVD) market which include the growing incidences of chronic and infectious diseases as well as the rise in geriatric population. In addition, the awareness of rare diseases and the increase in applications of personalized medicines support the growth of the IVD industry. Moreover, the rise in demand for technologically advanced diagnostic devices and growth in disposable income of consumers create opportunities for industry growth. Technological advancements for the development of high sensitivity point-of-care (POC) hematology testing would further boost the market growth. Nonetheless, hostile reimbursement policies and stringent government regulations are expected to impede the growth in the IVD industry.
In Vitro Diagnostics (IVD) Market Key Segmentation:
The report encompasses the IVD market segmentation based on product type, technique, indication, end users, and geography. Based on product type, the in vitro diagnostics market is divided into reagents, instruments, and services & software. The technique segment is classified as blood testing, immunodiagnostics, hematology, molecular diagnostics, clinical chemistry, tissue diagnostics, and other clinical techniques. By application, the industry is divided into infectious diseases, cancer, cardiac diseases, immune system disorders, gastrointestinal diseases, nephrological diseases, and other indications. By end-users, the market is categorized into standalone laboratory, hospitals, point of care, academics & medical schools, and others. The regional breakdown and detailed market analysis of each of the segments are included for regions such as North America, Asia-Pacific, Europe, and LAMEA.
Type
The report includes a mention of the key players operating in the in vitro diagnostics industry who implemented strategies such as product launches, expansion, and acquisition to grow their market presence. The prominent companies listed in the study include Affymetrix Inc., Alere Inc., Biomerieux, Danaher Corporation, Roche Diagnostics, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG., Arkray, Inc., Sysmex Corporation, Johnson and Johnson, and Siemens AG. Roche Diagnostic launched the new Cobas c513 analyzer in October 2015. Pall Corporation was acquired by Danaher Corporation in August 2015 to raise the latter’s expertise in life science and diagnostic market.
Key Benefits from the Report:
The research report provides a detailed analysis of the in vitro diagnostics industry with the help of IVD market size, IVD market share, IVD industry forecast, IVD market outlook, IVD market forecast, market drivers and restraints, opportunities, market segments, and key players operating in the field. The study is useful for market players, new entrants, and investors as it helps them understand the current market scenario and the latest trends and technologies related to the market. It helps them take informed decisions based on their business goals. The report offers an in-depth quantitative analysis of the current market and estimations from 2016 to 2025 to help identify of market opportunities. The in vitro diagnostics market size helps identify the audience to target the products or services of the industry. The in vitro diagnostics market size also helps understand the overall potential of the market. The market share analysis helps assess the performance of the players in the field. The market forecast is based on the current and past market trends. The drivers and restraints help assess the causes for the rise and fall of the market. Competitive analysis as well as profiles of key market players are also included in the report.
Progressive Markets published a report, “In Vitro Diagnostics (IVD) Market by segmented (instruments, reagents, and services & software), By End user (hospitals, standalone laboratory, academics & medical schools, point of care and others)-Global Industry opportunity, Analysis, Forecast, 2016-2025,” which says that the IVD market is expected to garner $91.3 billion by 2025, registering a CAGR of 4.5% from 2017 to 2025.
In vitro diagnostics (IVD) refers to the technique that makes use of medical reagents and devices to examine samples of tissues, urine, stool, blood, and other body fluids for the assessment of diseases and infections. The tests are conducted in hospital based laboratories, stand-alone laboratories, and point of care testing centers. Some of the important technologies used for test sample preparation include microarray techniques, mass spectrometry, polymerase chain reaction (PCR), and sequencing technology. Doctors and researchers have turned to personalized medicines from traditional diagnostic methods due to new innovations in IVD product designs and technologies.
Market Drivers and Restraints:
The report identifies the propellers of the in vitro diagnostics (IVD) market which include the growing incidences of chronic and infectious diseases as well as the rise in geriatric population. In addition, the awareness of rare diseases and the increase in applications of personalized medicines support the growth of the IVD industry. Moreover, the rise in demand for technologically advanced diagnostic devices and growth in disposable income of consumers create opportunities for industry growth. Technological advancements for the development of high sensitivity point-of-care (POC) hematology testing would further boost the market growth. Nonetheless, hostile reimbursement policies and stringent government regulations are expected to impede the growth in the IVD industry.
In Vitro Diagnostics (IVD) Market Key Segmentation:
The report encompasses the IVD market segmentation based on product type, technique, indication, end users, and geography. Based on product type, the in vitro diagnostics market is divided into reagents, instruments, and services & software. The technique segment is classified as blood testing, immunodiagnostics, hematology, molecular diagnostics, clinical chemistry, tissue diagnostics, and other clinical techniques. By application, the industry is divided into infectious diseases, cancer, cardiac diseases, immune system disorders, gastrointestinal diseases, nephrological diseases, and other indications. By end-users, the market is categorized into standalone laboratory, hospitals, point of care, academics & medical schools, and others. The regional breakdown and detailed market analysis of each of the segments are included for regions such as North America, Asia-Pacific, Europe, and LAMEA.
Type
- Reagents
- Instruments
- Services & Software
- Immunodiagnostics
- Hematology
- Blood testing
- Molecular diagnostics
- Clinical Chemistry
- Tissue Diagnostics
- Other clinical techniques
- Infectious Diseases
- Cancer
- Cardiac Diseases
- Immune System Disorders
- Nephrological Diseases
- Gastrointestinal Diseases
- Other Indications
- Standalone Laboratories
- Hospitals
- Academic and Medical schools
- Point of care testing
- Others
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Others
- Asia-Pacific
- India
- China
- Japan
- Australia
- Others
- LAMEA
- Latin America
- Middle East
- Africa
The report includes a mention of the key players operating in the in vitro diagnostics industry who implemented strategies such as product launches, expansion, and acquisition to grow their market presence. The prominent companies listed in the study include Affymetrix Inc., Alere Inc., Biomerieux, Danaher Corporation, Roche Diagnostics, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG., Arkray, Inc., Sysmex Corporation, Johnson and Johnson, and Siemens AG. Roche Diagnostic launched the new Cobas c513 analyzer in October 2015. Pall Corporation was acquired by Danaher Corporation in August 2015 to raise the latter’s expertise in life science and diagnostic market.
Key Benefits from the Report:
The research report provides a detailed analysis of the in vitro diagnostics industry with the help of IVD market size, IVD market share, IVD industry forecast, IVD market outlook, IVD market forecast, market drivers and restraints, opportunities, market segments, and key players operating in the field. The study is useful for market players, new entrants, and investors as it helps them understand the current market scenario and the latest trends and technologies related to the market. It helps them take informed decisions based on their business goals. The report offers an in-depth quantitative analysis of the current market and estimations from 2016 to 2025 to help identify of market opportunities. The in vitro diagnostics market size helps identify the audience to target the products or services of the industry. The in vitro diagnostics market size also helps understand the overall potential of the market. The market share analysis helps assess the performance of the players in the field. The market forecast is based on the current and past market trends. The drivers and restraints help assess the causes for the rise and fall of the market. Competitive analysis as well as profiles of key market players are also included in the report.
CHAPTER: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2027
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER: 3 WORLD IVD MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies
3.3 Porter five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Low threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry
3.4 Government regulations
3.5 Value chain analysis
3.6 Market share analysis, 2014
3.7 Market player positioning, 2015
3.8 Case studies
3.8.1 Case Study 1: Positioning of new IVD Platform by Life Science
3.8.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system
3.9 Research & Analysis
3.9.1 Clinical Trials of research studies conducted for IVD market
3.10 Significant Progressions in IVD technologies
3.10.1 Total Laboratory Automation (TLA)
3.10.2 Evolving markets in digital pathology
3.10.3 Omics and Genetics tests in IVD
3.10.4 Point-of-Care testing
3.10.5 Emerging technologies diagnostics and influence on IVD
3.11 Market dynamics
3.11.1 Drivers
3.11.1.1 Increasing incidences of chronic and infectious diseases
3.11.1.2 Technological advancements in IVD
3.11.1.3 Emergence of minimal invasive technologies
3.11.1.4 Increasing government expenditures on healthcare
3.11.1.5 Increase in popularity personalized medicine approach
3.11.2 Restraints
3.11.2.1 Unclear reimbursement policies
3.11.2.2 Stringent Regulatory policies
3.11.3 Opportunities
3.11.3.1 Potential Opportunities for outsourcing
3.11.3.2 Convergence of new Technologies.
CHAPTER: 4 MARKETBY PRODUCT TYPE, 2015-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Reagents
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Instruments
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Software and services
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
CHAPTER: 5 MARKETBY TECHNIQUES, 2015-2022
5.1 Overview
5.1.1 Market size and forecast
5.2 Immunodiagnostics
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence Immunoassay (CLIA)
5.2.4.2.1 MARKET SIZE AND FORECAST
5.2.4.3 Fluorescence immunoassay (FIA)
5.2.4.3.1 MARKET SIZE AND FORECAST
5.2.4.4 Colorimetric Immunoassay (CI)
5.2.4.4.1 MARKET SIZE AND FORECAST
5.2.5 Rapid Tests
5.2.5.1 Market size and forecast
5.2.6 Enzyme-Linked ImmunoSpot (ELISPOT)
5.2.6.1 Market size and forecast
5.2.7 Radioimmunoassay (RIA)
5.2.7.1 Market size and forecast
5.2.8 Western blot
5.2.8.1 Market size and forecast
5.3 Blood testing
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.4 Molecular diagnostics
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize Chain Reaction (PCR)
5.4.4.1 Market size and forecast
5.4.5 Isothermal Nucleic Acid Technology (INAAT)
5.4.5.1 Market size and forecast
5.4.6 Hybridization
5.4.6.1 Market size and forecast
5.4.7 DNA diagnostics
5.4.7.1 Market size and forecast
5.4.8 Microarray
5.4.8.1 Market size and forecast
5.4.9 Others
5.4.9.1 Market size and forecast
5.5 Tissue diagnostics
5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.6 Clinical chemistry
5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel
5.6.4.1 Market size and forecast
5.6.5 Liver panel
5.6.5.1 Market size and forecast
5.6.6 Renal profile
5.6.6.1 Market size and forecast
5.6.7 Lipid profile
5.6.7.1 Market size and forecast
5.6.8 Thyroid function panel
5.6.8.1 Market size and forecast
5.6.9 Electrolyte panel
5.6.9.1 Market size and forecast
5.6.10 Speciality chemicals
5.6.10.1 Market size and forecast
5.7 Other IVD techniques
5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast
CHAPTER: 6 MARKETBY INDICATION, 2015-2022
6.1 Overview
6.1.1 Market size and forecast
6.2 Infectious diseases
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Cancer
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.4 Cardiac diseases
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.5 Immune system diseases
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.6 Nephrological diseases
6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast
6.7 Gastrointestinal diseases
6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast
6.8 Other indications
6.8.1 Key market trends
6.8.2Key growth factors and opportunities
6.8.3Market size and forecast
CHAPTER: 7 MARKET BY END USERS, 2015-2022
7.1 Overview
7.1.1 Market size and forecast
7.2 Standalone laboratories
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Hospitals
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.4 Academic and Medical schools
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.5 Point of care testing
7.5.1 Key market trends
7.5.2 Growth factors and opportunities
7.5.3 Market size and forecast
7.6 Others
7.6.1 Key market trends
7.6.2 Key growth factors and opportunities
7.6.3 Market size and forecast
CHAPTER: 8 MARKET BY GEOGRAPHY, 2015-2022
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 United states
8.2.4.1 Market size and forecast
8.2.5 Canada
8.2.5.1 Market size and forecast
8.2.6 Mexico
8.2.6.1 Market size and forecast
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 Germany
8.3.4.1 Market size and forecast
8.3.5 France
8.3.5.1 Market size and forecast
8.3.6 United Kingdom
8.3.6.1 Market size and forecast
8.3.7 Others
8.3.7.1 Market size and forecast
8.4 Asia Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 India
8.4.4.1 Market size and forecast
8.4.5 China
8.4.5.1 Market size and forecast
8.4.6 Japan
8.4.6.1 Market size and forecast
8.4.7 Australia
8.4.7.1 Market size and forecast
8.4.8 Others
8.4.8.1 Market size and forecast
8.5 LAMEA
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.4 Latin America
8.5.4.1 Market size and forecast
8.5.5 Middle East
8.5.5.1 Market size and forecast
8.5.6 Africa
8.5.6.1 Market size and forecast
CHAPTER: 9 COMPANY PROFILES
9.1 Affymetrix Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Financial performance of Affymetrix Inc.
9.1.4 Key Strategies and development
9.1.5 SWOT analysis of Affymetrix
9.2 Alere Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Key strategies and developments
9.2.5 SWOT analysis of Alere
9.3 Biomerieux
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Key strategies and developments
9.3.5 SWOT analysis of BioMerieux
9.4 Danaher Corporation.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Key strategies and development
9.4.5 SWOT analysis of Danaher Corporation
9.5 Roche Diagnostics
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business performance
9.5.4 Key strategies and developments
9.5.5 SWOT analysis of Roche Diagnostics
9.6 Becton Dickinson and Company
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Business performance
9.6.4 Key strategies and development
9.6.5 SWOT analysis of Becton Dickinson and Company
9.7 Bio-Rad Laboratories, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Business performance
9.7.4 Key strategies and developments
9.7.5 SWOT analysis of Bio-Rad Laboratories, Inc.
9.8 Abbott Laboratories
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business performance
9.8.4 Key strategies and developments
9.8.5 SWOT analysis of Abbott Laboratories
9.9 Bayer AG.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Business performance
9.9.4 Key strategies and development
9.9.5 SWOT analysis of Bayer AG
9.10 Arkray, Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Key strategies and development
9.10.4 SWOT analysis of Arkray, Inc.
9.11 Sysmex Corporation
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Business performance
9.11.4 Key strategies and developments
9.11.5 SWOT analysis of Sysmex Corporation
9.12 Johnson & Johnson Pvt Ltd.
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Business performance
9.12.4 Key strategies and development
9.12.5 SWOT analysis of Johnson & Johnson Pvt Ltd.
9.13 Siemens AG
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Business performance
9.13.4 Key strategies and development
9.13.5 SWOT analysis of Siemens AG
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2027
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER: 3 WORLD IVD MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies
3.3 Porter five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Low threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry
3.4 Government regulations
3.5 Value chain analysis
3.6 Market share analysis, 2014
3.7 Market player positioning, 2015
3.8 Case studies
3.8.1 Case Study 1: Positioning of new IVD Platform by Life Science
3.8.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system
3.9 Research & Analysis
3.9.1 Clinical Trials of research studies conducted for IVD market
3.10 Significant Progressions in IVD technologies
3.10.1 Total Laboratory Automation (TLA)
3.10.2 Evolving markets in digital pathology
3.10.3 Omics and Genetics tests in IVD
3.10.4 Point-of-Care testing
3.10.5 Emerging technologies diagnostics and influence on IVD
3.11 Market dynamics
3.11.1 Drivers
3.11.1.1 Increasing incidences of chronic and infectious diseases
3.11.1.2 Technological advancements in IVD
3.11.1.3 Emergence of minimal invasive technologies
3.11.1.4 Increasing government expenditures on healthcare
3.11.1.5 Increase in popularity personalized medicine approach
3.11.2 Restraints
3.11.2.1 Unclear reimbursement policies
3.11.2.2 Stringent Regulatory policies
3.11.3 Opportunities
3.11.3.1 Potential Opportunities for outsourcing
3.11.3.2 Convergence of new Technologies.
CHAPTER: 4 MARKETBY PRODUCT TYPE, 2015-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Reagents
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Instruments
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Software and services
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
CHAPTER: 5 MARKETBY TECHNIQUES, 2015-2022
5.1 Overview
5.1.1 Market size and forecast
5.2 Immunodiagnostics
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence Immunoassay (CLIA)
5.2.4.2.1 MARKET SIZE AND FORECAST
5.2.4.3 Fluorescence immunoassay (FIA)
5.2.4.3.1 MARKET SIZE AND FORECAST
5.2.4.4 Colorimetric Immunoassay (CI)
5.2.4.4.1 MARKET SIZE AND FORECAST
5.2.5 Rapid Tests
5.2.5.1 Market size and forecast
5.2.6 Enzyme-Linked ImmunoSpot (ELISPOT)
5.2.6.1 Market size and forecast
5.2.7 Radioimmunoassay (RIA)
5.2.7.1 Market size and forecast
5.2.8 Western blot
5.2.8.1 Market size and forecast
5.3 Blood testing
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.4 Molecular diagnostics
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize Chain Reaction (PCR)
5.4.4.1 Market size and forecast
5.4.5 Isothermal Nucleic Acid Technology (INAAT)
5.4.5.1 Market size and forecast
5.4.6 Hybridization
5.4.6.1 Market size and forecast
5.4.7 DNA diagnostics
5.4.7.1 Market size and forecast
5.4.8 Microarray
5.4.8.1 Market size and forecast
5.4.9 Others
5.4.9.1 Market size and forecast
5.5 Tissue diagnostics
5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.6 Clinical chemistry
5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel
5.6.4.1 Market size and forecast
5.6.5 Liver panel
5.6.5.1 Market size and forecast
5.6.6 Renal profile
5.6.6.1 Market size and forecast
5.6.7 Lipid profile
5.6.7.1 Market size and forecast
5.6.8 Thyroid function panel
5.6.8.1 Market size and forecast
5.6.9 Electrolyte panel
5.6.9.1 Market size and forecast
5.6.10 Speciality chemicals
5.6.10.1 Market size and forecast
5.7 Other IVD techniques
5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast
CHAPTER: 6 MARKETBY INDICATION, 2015-2022
6.1 Overview
6.1.1 Market size and forecast
6.2 Infectious diseases
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Cancer
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.4 Cardiac diseases
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.5 Immune system diseases
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.6 Nephrological diseases
6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast
6.7 Gastrointestinal diseases
6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast
6.8 Other indications
6.8.1 Key market trends
6.8.2Key growth factors and opportunities
6.8.3Market size and forecast
CHAPTER: 7 MARKET BY END USERS, 2015-2022
7.1 Overview
7.1.1 Market size and forecast
7.2 Standalone laboratories
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Hospitals
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.4 Academic and Medical schools
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.5 Point of care testing
7.5.1 Key market trends
7.5.2 Growth factors and opportunities
7.5.3 Market size and forecast
7.6 Others
7.6.1 Key market trends
7.6.2 Key growth factors and opportunities
7.6.3 Market size and forecast
CHAPTER: 8 MARKET BY GEOGRAPHY, 2015-2022
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 United states
8.2.4.1 Market size and forecast
8.2.5 Canada
8.2.5.1 Market size and forecast
8.2.6 Mexico
8.2.6.1 Market size and forecast
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 Germany
8.3.4.1 Market size and forecast
8.3.5 France
8.3.5.1 Market size and forecast
8.3.6 United Kingdom
8.3.6.1 Market size and forecast
8.3.7 Others
8.3.7.1 Market size and forecast
8.4 Asia Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 India
8.4.4.1 Market size and forecast
8.4.5 China
8.4.5.1 Market size and forecast
8.4.6 Japan
8.4.6.1 Market size and forecast
8.4.7 Australia
8.4.7.1 Market size and forecast
8.4.8 Others
8.4.8.1 Market size and forecast
8.5 LAMEA
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.4 Latin America
8.5.4.1 Market size and forecast
8.5.5 Middle East
8.5.5.1 Market size and forecast
8.5.6 Africa
8.5.6.1 Market size and forecast
CHAPTER: 9 COMPANY PROFILES
9.1 Affymetrix Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Financial performance of Affymetrix Inc.
9.1.4 Key Strategies and development
9.1.5 SWOT analysis of Affymetrix
9.2 Alere Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Key strategies and developments
9.2.5 SWOT analysis of Alere
9.3 Biomerieux
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Key strategies and developments
9.3.5 SWOT analysis of BioMerieux
9.4 Danaher Corporation.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Key strategies and development
9.4.5 SWOT analysis of Danaher Corporation
9.5 Roche Diagnostics
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business performance
9.5.4 Key strategies and developments
9.5.5 SWOT analysis of Roche Diagnostics
9.6 Becton Dickinson and Company
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Business performance
9.6.4 Key strategies and development
9.6.5 SWOT analysis of Becton Dickinson and Company
9.7 Bio-Rad Laboratories, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Business performance
9.7.4 Key strategies and developments
9.7.5 SWOT analysis of Bio-Rad Laboratories, Inc.
9.8 Abbott Laboratories
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business performance
9.8.4 Key strategies and developments
9.8.5 SWOT analysis of Abbott Laboratories
9.9 Bayer AG.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Business performance
9.9.4 Key strategies and development
9.9.5 SWOT analysis of Bayer AG
9.10 Arkray, Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Key strategies and development
9.10.4 SWOT analysis of Arkray, Inc.
9.11 Sysmex Corporation
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Business performance
9.11.4 Key strategies and developments
9.11.5 SWOT analysis of Sysmex Corporation
9.12 Johnson & Johnson Pvt Ltd.
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Business performance
9.12.4 Key strategies and development
9.12.5 SWOT analysis of Johnson & Johnson Pvt Ltd.
9.13 Siemens AG
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Business performance
9.13.4 Key strategies and development
9.13.5 SWOT analysis of Siemens AG
LIST OF TABLES
TABLE 1 WORLD IVD BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 2 WORLD IVD RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 3 WORLD IVD DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 4 PORTERS FIVE FORCES ANALYSIS
TABLE 5 MARKET SHARE AND REVENUE OF CRPC DRUG INNOVATORS
TABLE 6 CLINICAL TRIALS - IN VITRO DIAGNOSTIC DEVICES
TABLE 7 GLOBAL INCIDENCES OF DISEASES
TABLE 8 MARKETBY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 9 MARKETBY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 10 WORLD IVD REAGENTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 11 WORLD IVD INSTRUMENTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 12 WORLD IVD SOFTWARE AND SERVICES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 13 MARKET BY TECHNIQUE, 2015-2022 ($MILLION)
TABLE 14 WORLD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 15 WORLD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 16 WORLD ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) MARKET, 2015-2022 ($MILLION)
TABLE 17 WORLD BLOOD TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 18 WORLD MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2015-2022 ($MILLION)
TABLE 19 WORLD MOLECULAR DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 20 WORLD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2015-2022, ($MILLION)
TABLE 21 WORLD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 22 WORLD OTHER CLINICAL TECHNIQUES MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 23 WORLD IVD MARKET, BY INDICATION, 2015-2022 ($MILLION)
TABLE 24 WORLD IVD INFECTIOUS DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 25 WORLD IVD CANCER MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 26 WORLD IVD CARDIAC DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 27 WORLD IVD IMMUNE SYSTEM DISORDER MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 28 WORLD IVD NEPHROLOGICAL DISEASES MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 29 WORLD IVD GASTRINTESTINAL DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 30 WORLD IVD OTHER INDICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 31 MARKETBY END USER, 2015-2022, ($MILLION)
TABLE 32 WORLD IVD STANDALONE LABORATORIES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 33 WORLD IVD HOSPITALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 34 WORLD IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY GEOGRAPHY, 2015- 2022 ($MILLION)
TABLE 35 WORLD IVD POINT OF CARE TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 36 WORLD IVD OTHERS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 37 WORLD IVD MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 38 NORTH AMERICA IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 39 UNITED STATES IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 40 CANADA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 41 MEXICO IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 42 EUROPE IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 43 GERMANY IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 44 FRANCE IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 45 UNITED KINGDOM IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 46 OTHERS EUROPEAN IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 47 ASIA PACIFIC IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 48 INDIA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 49 CHINA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 50 JAPAN IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 51 CATEGORIZATION OF IVD DEVICES
TABLE 52 AUSTRALIA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 53 OTHERS IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 54 LAMEA IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 55 LATIN AMERICA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 56 MIDDLE EAST IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 57 AFRICA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 58 COMPANY SNAPSHOT OF AFFYMETRIX INC.
TABLE 59 ALERE INC. COMPANY SNAPSHOT
TABLE 60 BIOMERIEUX COMPANY SNAPSHOT
TABLE 61 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 62 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 63 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 64 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 65 ABBOTT LABORATORIES SNAPSHOT
TABLE 66 BAYER AG COMPANY SNAPSHOT
TABLE 67 ARKRAY, INC. COMPANY SNAPSHOT
TABLE 68 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 69 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT
TABLE 70 SIEMENS AGCOMPANY SNAPSHOT
TABLE 1 WORLD IVD BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 2 WORLD IVD RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 3 WORLD IVD DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 4 PORTERS FIVE FORCES ANALYSIS
TABLE 5 MARKET SHARE AND REVENUE OF CRPC DRUG INNOVATORS
TABLE 6 CLINICAL TRIALS - IN VITRO DIAGNOSTIC DEVICES
TABLE 7 GLOBAL INCIDENCES OF DISEASES
TABLE 8 MARKETBY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 9 MARKETBY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 10 WORLD IVD REAGENTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 11 WORLD IVD INSTRUMENTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 12 WORLD IVD SOFTWARE AND SERVICES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 13 MARKET BY TECHNIQUE, 2015-2022 ($MILLION)
TABLE 14 WORLD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 15 WORLD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 16 WORLD ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) MARKET, 2015-2022 ($MILLION)
TABLE 17 WORLD BLOOD TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 18 WORLD MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2015-2022 ($MILLION)
TABLE 19 WORLD MOLECULAR DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 20 WORLD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2015-2022, ($MILLION)
TABLE 21 WORLD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 22 WORLD OTHER CLINICAL TECHNIQUES MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 23 WORLD IVD MARKET, BY INDICATION, 2015-2022 ($MILLION)
TABLE 24 WORLD IVD INFECTIOUS DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 25 WORLD IVD CANCER MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 26 WORLD IVD CARDIAC DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 27 WORLD IVD IMMUNE SYSTEM DISORDER MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 28 WORLD IVD NEPHROLOGICAL DISEASES MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 29 WORLD IVD GASTRINTESTINAL DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 30 WORLD IVD OTHER INDICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 31 MARKETBY END USER, 2015-2022, ($MILLION)
TABLE 32 WORLD IVD STANDALONE LABORATORIES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 33 WORLD IVD HOSPITALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 34 WORLD IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY GEOGRAPHY, 2015- 2022 ($MILLION)
TABLE 35 WORLD IVD POINT OF CARE TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 36 WORLD IVD OTHERS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 37 WORLD IVD MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 38 NORTH AMERICA IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 39 UNITED STATES IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 40 CANADA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 41 MEXICO IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 42 EUROPE IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 43 GERMANY IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 44 FRANCE IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 45 UNITED KINGDOM IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 46 OTHERS EUROPEAN IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 47 ASIA PACIFIC IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 48 INDIA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 49 CHINA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 50 JAPAN IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 51 CATEGORIZATION OF IVD DEVICES
TABLE 52 AUSTRALIA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 53 OTHERS IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 54 LAMEA IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 55 LATIN AMERICA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 56 MIDDLE EAST IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 57 AFRICA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 58 COMPANY SNAPSHOT OF AFFYMETRIX INC.
TABLE 59 ALERE INC. COMPANY SNAPSHOT
TABLE 60 BIOMERIEUX COMPANY SNAPSHOT
TABLE 61 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 62 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 63 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 64 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 65 ABBOTT LABORATORIES SNAPSHOT
TABLE 66 BAYER AG COMPANY SNAPSHOT
TABLE 67 ARKRAY, INC. COMPANY SNAPSHOT
TABLE 68 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 69 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT
TABLE 70 SIEMENS AGCOMPANY SNAPSHOT
LIST OF FIGURES
FIG. 1 WORLD IVD MARKET SNAPSHOT
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 TOP IMPACTING FACTORS
FIG. 5 TOP INVESTMENT POCKETS OF IVD MARKET BY TECHNIQUES 2015-2022.
FIG. 6 TOP WINNING STRATEGIES
FIG. 7 TOP WINNING STRATEGIES
FIG. 8 VALUE CHAIN ANALYSIS FOR IVD MARKET
FIG. 9 MARKET SHARE OF KEY PLAYERS IN IVD MARKET
FIG. 10 MARKET PLAYER POSITIONING, 2014
FIG. 11 WORLD CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2015-2022 ($MILLION)
FIG. 12 WORLD FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2015-2022 ($MILLION)
FIG. 13 WORLD COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2015-2022 ($MILLION)
FIG. 14 WORLD RAPID TESTS MARKET, 2015-2022 ($MILLION)
FIG. 15 WORLD ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2015-2022 ($MILLION)
FIG. 16 WORLD RADIOIMMUNOASSAY (RIA) MARKET, 2015-2022 ($MILLION)
FIG. 17 WORLD WESTERN BLOT TECHNIQUE MARKET, 2015-2022 ($MILLION)
FIG. 18 WORLD POLYMERIZE CHAIN REACTION PCR MARKET, 2015-2022 ($MILLION)
FIG. 19 WORLD ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2015-2022 ($MILLION)
FIG. 20 WORLD HYBRIDIZATION MARKET, 2015-2022 ($MILLION)
FIG. 21 WORLD DNA DIAGNOSTICS MARKET, 2015-2022 ($MILLION)
FIG. 22 WORLD MICROARRAY MARKET, 2015-2022 ($MILLION)
FIG. 23 WORLD OTHER MOLECULAR DIAGNOSTIC MARKET, 2015-2022 ($MILLION)
FIG. 24 WORLD BASIC METABOLIC PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 25 WORLD LIVER PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 26 WORLD RENAL PROFILE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 27 WORLD LIPID PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 28 WORLD THYROID FUNCTION PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 29 WORLD ELECTROLYTE PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 30 WORLD SPECIALITY CHEMICALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 31 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE, 2012-2014, $MILLION
FIG. 32 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE BY SEGMENTS
FIG. 33 KEY FINANCIALS OF AFFYMETRIX INC.CORPORATION REVENUE BY GEOGRAPHY
FIG. 34 SWOT ANALYSIS OF AFFYMETRIX INC.
FIG. 35 KEY FINANCIALS OF ALERE INC. REVENUE, 2012-2014, $MILLION
FIG. 36 ALERE INC., % NET SALES BY BUSINESS SEGMENTS, 2014
FIG. 37 ALERE INC., % NET SALES BY GEOGRAPHY, 2014
FIG. 38 SWOT ANALYSIS OF ALERE INC.
FIG. 39 KEY FINANCIALS OF BIOMERIEUX REVENUE, 2011-2014, $MILLION
FIG. 40 BIOMERIEUX, % NET SALES BY TECHNOLOGY, 2014
FIG. 41 BIOMERIEUX, % NET SALES BY GEOGRAPHY, 2014
FIG. 42 SWOT ANALYSIS OF BIOMERIEUX
FIG. 43 DANAHER CORPORATION, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 44 DANAHER CORPORATION, % NET SALES BY GEOGRAPHY, 2014
FIG. 45 SWOT ANALYSIS OF DANAHER CORPORATION
FIG. 46 KEY FINANCIALS OF ROCHE DIAGNOSTICS REVENUE, 2012-2014, $MILLION
FIG. 47 ROCHE DIAGNOSTICS, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 48 ROCHE DIAGNOSTICS, % NET SALES BY GEOGRAPHY, 2014
FIG. 49 SWOT ANALYSIS OF ROCHE DIAGNOSTICS
FIG. 50 KEY FINANCIALS OF BECTON, DICKINSON AND COMPANY REVENUE, 2011-2014, $MILLION
FIG. 51 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY REVENUES BY SEGMENT 2014
FIG. 52 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY SALES BY GEOGRAPHY 2014
FIG. 53 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY
FIG. 54 KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 55 BIO RAD LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 56 BIO RAD LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 57 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.
FIG. 58 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 59 ABBOTT LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 60 ABBOTT LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 61 SWOT ANALYSIS OF ABBOTT LABORATORIES
FIG. 62 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 63 BAYER AG, % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 64 SWOT ANALYSIS OF BAYER AG
FIG. 65 SWOT ANALYSIS OF ARKRAY, INC.
FIG. 66 KEY FINANCIALS OF SYSMEX CORPORATION REVENUE, 2012-2014, $MILLION
FIG. 67 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014
FIG. 68 SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014
FIG. 69 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)
FIG. 70 SWOT ANALYSIS OF SYSMEX CORPORATION
FIG. 71 KEY FINANCIALS OF JOHNSON & JOHSNON $MILLION (2012-2014)
FIG. 72 FINANCIAL REVENUES BY SEGMENTS (2014)
FIG. 73 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 74 SWOT ANALYSIS OF JOHNSON & JOHNSON PVT LTD.
FIG. 75 SIEMENS AG., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 76 SIEMENS AG., % REVENUE BY GEOGRAPHY, 2014
FIG. 77 SWOT ANALYSIS OF SIEMENS AG
FIG. 1 WORLD IVD MARKET SNAPSHOT
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 TOP IMPACTING FACTORS
FIG. 5 TOP INVESTMENT POCKETS OF IVD MARKET BY TECHNIQUES 2015-2022.
FIG. 6 TOP WINNING STRATEGIES
FIG. 7 TOP WINNING STRATEGIES
FIG. 8 VALUE CHAIN ANALYSIS FOR IVD MARKET
FIG. 9 MARKET SHARE OF KEY PLAYERS IN IVD MARKET
FIG. 10 MARKET PLAYER POSITIONING, 2014
FIG. 11 WORLD CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2015-2022 ($MILLION)
FIG. 12 WORLD FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2015-2022 ($MILLION)
FIG. 13 WORLD COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2015-2022 ($MILLION)
FIG. 14 WORLD RAPID TESTS MARKET, 2015-2022 ($MILLION)
FIG. 15 WORLD ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2015-2022 ($MILLION)
FIG. 16 WORLD RADIOIMMUNOASSAY (RIA) MARKET, 2015-2022 ($MILLION)
FIG. 17 WORLD WESTERN BLOT TECHNIQUE MARKET, 2015-2022 ($MILLION)
FIG. 18 WORLD POLYMERIZE CHAIN REACTION PCR MARKET, 2015-2022 ($MILLION)
FIG. 19 WORLD ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2015-2022 ($MILLION)
FIG. 20 WORLD HYBRIDIZATION MARKET, 2015-2022 ($MILLION)
FIG. 21 WORLD DNA DIAGNOSTICS MARKET, 2015-2022 ($MILLION)
FIG. 22 WORLD MICROARRAY MARKET, 2015-2022 ($MILLION)
FIG. 23 WORLD OTHER MOLECULAR DIAGNOSTIC MARKET, 2015-2022 ($MILLION)
FIG. 24 WORLD BASIC METABOLIC PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 25 WORLD LIVER PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 26 WORLD RENAL PROFILE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 27 WORLD LIPID PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 28 WORLD THYROID FUNCTION PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 29 WORLD ELECTROLYTE PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 30 WORLD SPECIALITY CHEMICALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 31 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE, 2012-2014, $MILLION
FIG. 32 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE BY SEGMENTS
FIG. 33 KEY FINANCIALS OF AFFYMETRIX INC.CORPORATION REVENUE BY GEOGRAPHY
FIG. 34 SWOT ANALYSIS OF AFFYMETRIX INC.
FIG. 35 KEY FINANCIALS OF ALERE INC. REVENUE, 2012-2014, $MILLION
FIG. 36 ALERE INC., % NET SALES BY BUSINESS SEGMENTS, 2014
FIG. 37 ALERE INC., % NET SALES BY GEOGRAPHY, 2014
FIG. 38 SWOT ANALYSIS OF ALERE INC.
FIG. 39 KEY FINANCIALS OF BIOMERIEUX REVENUE, 2011-2014, $MILLION
FIG. 40 BIOMERIEUX, % NET SALES BY TECHNOLOGY, 2014
FIG. 41 BIOMERIEUX, % NET SALES BY GEOGRAPHY, 2014
FIG. 42 SWOT ANALYSIS OF BIOMERIEUX
FIG. 43 DANAHER CORPORATION, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 44 DANAHER CORPORATION, % NET SALES BY GEOGRAPHY, 2014
FIG. 45 SWOT ANALYSIS OF DANAHER CORPORATION
FIG. 46 KEY FINANCIALS OF ROCHE DIAGNOSTICS REVENUE, 2012-2014, $MILLION
FIG. 47 ROCHE DIAGNOSTICS, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 48 ROCHE DIAGNOSTICS, % NET SALES BY GEOGRAPHY, 2014
FIG. 49 SWOT ANALYSIS OF ROCHE DIAGNOSTICS
FIG. 50 KEY FINANCIALS OF BECTON, DICKINSON AND COMPANY REVENUE, 2011-2014, $MILLION
FIG. 51 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY REVENUES BY SEGMENT 2014
FIG. 52 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY SALES BY GEOGRAPHY 2014
FIG. 53 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY
FIG. 54 KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 55 BIO RAD LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 56 BIO RAD LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 57 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.
FIG. 58 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 59 ABBOTT LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 60 ABBOTT LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 61 SWOT ANALYSIS OF ABBOTT LABORATORIES
FIG. 62 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 63 BAYER AG, % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 64 SWOT ANALYSIS OF BAYER AG
FIG. 65 SWOT ANALYSIS OF ARKRAY, INC.
FIG. 66 KEY FINANCIALS OF SYSMEX CORPORATION REVENUE, 2012-2014, $MILLION
FIG. 67 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014
FIG. 68 SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014
FIG. 69 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)
FIG. 70 SWOT ANALYSIS OF SYSMEX CORPORATION
FIG. 71 KEY FINANCIALS OF JOHNSON & JOHSNON $MILLION (2012-2014)
FIG. 72 FINANCIAL REVENUES BY SEGMENTS (2014)
FIG. 73 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 74 SWOT ANALYSIS OF JOHNSON & JOHNSON PVT LTD.
FIG. 75 SIEMENS AG., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 76 SIEMENS AG., % REVENUE BY GEOGRAPHY, 2014
FIG. 77 SWOT ANALYSIS OF SIEMENS AG
